Literature DB >> 6138515

Intranasal interferon for contact prophylaxis against common cold in families.

C Herzog, M Just, R Berger, L Havas, M Fernex.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6138515     DOI： 10.1016/s0140-6736(83)90470-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Biodegradable nanogels for oral delivery of interferon for norovirus infection.

Authors:  Yunjeong Kim; Mahendra Thapa; Duy H Hua; Kyeong-Ok Chang
Journal:  Antiviral Res       Date:  2010-12-07       Impact factor: 5.970

Review 2.  Antiviral therapy. Respiratory infections, genital herpes, and herpetic keratitis.

Authors:  K G Nicholson
Journal:  Lancet       Date:  1984-09-15       Impact factor: 79.321

Review 3.  Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.

Authors:  Tony Velkov; Nusaibah Abdul Rahim; Qi Tony Zhou; Hak-Kim Chan; Jian Li
Journal:  Adv Drug Deliv Rev       Date:  2014-11-12       Impact factor: 15.470

Review 4.  Review: The Nose as a Route for Therapy. Part 2 Immunotherapy.

Authors:  Yorissa Padayachee; Sabine Flicker; Sophia Linton; John Cafferkey; Onn Min Kon; Sebastian L Johnston; Anne K Ellis; Martin Desrosiers; Paul Turner; Rudolf Valenta; Glenis Kathleen Scadding
Journal:  Front Allergy       Date:  2021-07-01

5.  Tolerance of one-month intranasal interferon.

Authors:  G M Scott; J K Onwubalili; J A Robinson; C Doré; D S Secher; K Cantell
Journal:  J Med Virol       Date:  1985-10       Impact factor: 2.327

6.  Activated interferon system in healthy homosexual men.

Authors:  S Levin; T Hahn; Z T Handzel; E Galili-Wiesstub; V Bregman; R Myer; M Tinowitz; Y Altman; N Barzilai; Y Brenner
Journal:  Antiviral Res       Date:  1985-08       Impact factor: 5.970
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.